113 related articles for article (PubMed ID: 38271824)
1. Study of novel ginsenoside metabolites targeting HSP70 as anti-prostate cancer drugs.
Xu L; Xiao S; Chai Z; Li T; Joon Lee J; Su G; Zhao Y
Bioorg Chem; 2024 Mar; 144():107131. PubMed ID: 38271824
[TBL] [Abstract][Full Text] [Related]
2. New perspective on the metabolism of AD-1 in vivo: Characterization of a series of dammarane-type derivatives with novel metabolic sites and anticancer mechanisms of active oleanane-type metabolites.
Ding M; Wang X; Zhang Y; Yuan W; Zhang H; Xu L; Wang Z; Lu J; Li W; Zhao Y
Bioorg Chem; 2019 Jul; 88():102961. PubMed ID: 31075741
[TBL] [Abstract][Full Text] [Related]
3. A combined network pharmacology and molecular biology approach to investigate the potential mechanisms of G-M6 on ovarian cancer.
Ding M; Dong C; Mao Y; Liu S; Zhao Y; Wang X
Bioorg Chem; 2023 Sep; 138():106657. PubMed ID: 37302316
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 suppresses the proliferation of prostate cancer cell line PC3 through ROS-induced cell cycle arrest.
Peng Y; Zhang R; Yang X; Zhang Z; Kang N; Bao L; Shen Y; Yan H; Zheng F
Oncol Lett; 2019 Jan; 17(1):1139-1145. PubMed ID: 30655875
[TBL] [Abstract][Full Text] [Related]
5. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
7. Panaxadiol as a major metabolite of AD-1 can significantly inhibit the proliferation and migration of breast cancer cells: In vitro and in vivo study.
Xu L; Zhang X; Xiao S; Li X; Jiang H; Wang Z; Sun B; Zhao Y
Bioorg Chem; 2021 Nov; 116():105392. PubMed ID: 34619469
[TBL] [Abstract][Full Text] [Related]
8. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
Wang W; Wang H; Rayburn ER; Zhao Y; Hill DL; Zhang R
Br J Cancer; 2008 Feb; 98(4):792-802. PubMed ID: 18253123
[TBL] [Abstract][Full Text] [Related]
9. Biological Effects of Hesperetin on Interleukin-6/Phosphorylated Signal Transducer and Activator of Transcription 3 Pathway Signaling in Prostate Cancer PC3 Cells.
Shirzad M; Heidarian E; Beshkar P; Gholami-Arjenaki M
Pharmacognosy Res; 2017; 9(2):188-194. PubMed ID: 28539744
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis.
Xu G; Zou WQ; Du SJ; Wu MJ; Xiang TX; Luo ZG
Life Sci; 2016 Jul; 157():1-11. PubMed ID: 27234895
[TBL] [Abstract][Full Text] [Related]
11. eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.
Li Q; Xiao M; Shi Y; Hu J; Bi T; Wang C; Yan L; Li X
BMC Cancer; 2021 Sep; 21(1):1022. PubMed ID: 34525951
[TBL] [Abstract][Full Text] [Related]
12. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
13. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
14.
Hanafi MMM; Afzan A; Yaakob H; Aziz R; Sarmidi MR; Wolfender JL; Prieto JM
Front Pharmacol; 2017; 8():895. PubMed ID: 29326585
[TBL] [Abstract][Full Text] [Related]
15. Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.
Lu S; Tan Z; Wortman M; Lu S; Dong Z
Int J Oncol; 2010 Feb; 36(2):459-67. PubMed ID: 20043082
[TBL] [Abstract][Full Text] [Related]
16. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
17. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
18. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
[TBL] [Abstract][Full Text] [Related]
19. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
[TBL] [Abstract][Full Text] [Related]
20. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
